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RESEARCH LETTER
Non-invasive method for airway
clearance in a patient with
but  it  was  not  successful  probably  because  of  the  migration
of  the  obstruction  point  toward  the  periphery  of  the  airways
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collapse: A case study
Dear  Editor,
I  am  writing  you  this  letter  to  present  the  case  of  a  lady
affected  by  Excessive  Dynamic  Airway  Collapse  (EDAC)  who
subsequently  felt  better  when  treated  with  the  simple  tool
which  is  explained  as  follows.
EDAC  is  deﬁned  as  the  pathological  collapse  and  nar-
rowing  of  the  airway  lumen  by  50%  or  more  in  the  sagittal
diameter;  which  is  entirely  due  to  the  laxity  of  the  posterior
wall  membrane  with  structurally  intact  airway  cartilage.1,2
EDAC  is  usually  asymptomatic;  when  severe,  it  can  cause
refractory  cough,  dyspnea,  inability  to  clear  secretions,
pneumonia,  respiratory  failure,  and  wheezing  resistant  to
drugs.1 A  variety  of  treatment  options  has  been  suggested
for  EDAC,  but  large  controlled  studies  are  needed  to  conﬁrm
their  efﬁcacy.2,3
This  is  the  case  of  a  non-smoker  86-year-old  woman
(JAT)  who  signed  an  informed  consent  form.  JAT  is  a  house-
wife,  has  no  risk  factors  for  respiratory  diseases  but  several
comorbidities  including  anxiety  and  depression  in  treat-
ment.
In  2004  she  started  having  dyspnea  at  rest  and  orthop-
noea,  which  were  attributed  to  anxiety.  At  the  beginning
of  2007  severe  EDAC  was  diagnosed  by  bronchoscopy
(Figs.  1A  and  2A--D).  The  spirometry  showed  reduction  of
forced  expiratory  ﬂow  at  low  lung  volumes:  Forced  Expira-
tory  ﬂow  at  25--75%  of  vital  capacity  (FEF25-75)  was  40%
of  predicted  and  complete  intrathoracic  expiratory  ﬂow-
limitation  during  tidal  breathing.  After  Albuterole  400  g
forced  expiratory  ﬂow  at  low  lung  volume  improved  (FEF
25--75  was  49%  of  predicted  value).  She  started  therapy  with
Formoterol/Fluticasone  6/100  g.
As  it  was  suggested  that  nocturnal  and  intermittent  day-
time  use  of  CPAP  kept  the  airway  opened  and  improved
sputum  production  in  EDAC  patients,2,3 nocturnal  CPAP
(11  cmH2O)  with  facial  mask  (she  could  not  tolerate  nasalPlease  cite  this  article  in  press  as:  Bertella  E,  et  al.  Non-invasiv
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mask)  was  used:  sleep  quality  and  orthopnoea  improved.
In  December  2007  JAT  underwent  endoscopic  laser
treatment  with  poor  results  and  in  September  2008  an  endo-
luminal  silicone  y-stent  (Dumon  type)  was  inserted  (Fig.  1B),
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The  following  December  it  was  replaced  by  a  fully  cov-
red  metal  stent  (Leufen)  (Fig.  1C  and  D),  which  was
emoved  in  February  2009  because  of  granulation  tissue
rowth  and  viscous  secretion.
The  severity  of  EDAC  accordingly  to  Murgu  classiﬁcation
ystem4 was:  F3,  E3,  S3,  M:  crescent  type,  O:  idiopathic.
From  2007  to  2009  JAT  underwent  several  bronchoscopies
o  clear  secretions  (at  least  15);  her  quality  of  life  (mean
Q-5D  score  50)  was  very  poor.
In  March  2010  she  was  admitted  to  the  pulmonary  reha-
ilitation  department  for  respiratory  care  with:
-  one  daily  gym  group-session
-  Joint  mobilization/limb  training  with  ‘‘unloaded’’
arm/leg  exercise
-  Airways  clearance  with  threshold-Positive  Expiratory
Pressure  (tPEP),  set  at  8  cmH2O.
CPAP  improved  sleep  quality,  but  during  bike  training  it
as  not  helpful  and  severe  dyspnea  occurred.  We  then  tried
o  training  the  arm  bike  with  the  application  of  non-invasive
entilation  (NIV)  using  BPAP  Synchrony  S/T  with  inspiratory
ositive  airway  pressure  16  and  expiratory  positive  airway
ressure  8,  with  humidiﬁcation  included  and  facial  mask
F&P  HC  431).  Although  there  is  no  evidence  that  NIV  can
mprove  exercise  training  in  EDAC  patients,  we  tried  this
ool  which  is  commonly  used  with  COPD  patients8 to  unload
espiratory  muscles  and  increase  exercise  tolerance.
JAT  also  continued  airways  clearance  exercises  (t-PEP)
ith  modest  results  and  in  June,  she  was  readmitted  to  the
ulmonary  Rehabilitation  department.
We  were  aware  that  airway  clearance  was  the  major  goal
o  achieve.  To  the  best  of  our  knowledge  there  are  no  data
n  the  use  of  clearing  secretions  techniques  in  EDAC.  Only
ositive  expiratory  pressure  is  accepted.3
As  EDAC  is  a  condition  in  which  airways  collapse  during
orced  expiration  and  cough,  treatment  modalities  for  air-
ay  clearance  that  increase  inspiratory  volume  or  expiratorye  method  for  airway  clearance  in  a  patient  with  excessive
.  http://dx.doi.org/10.1016/j.rppnen.2016.08.004
ow  rate  should  not  be  considered.
We  tried  High  Frequency  Chest  Wall  Oscillator  (HFCWO  --
est® System,  Model  105  --  Home  Care,  HillRom),  an  inﬂat-
ble  jacket  (Vest)  worn  over  the  chest  connected  to  an  air
Elsevier Espan˜a, S.L.U. This is an open access article under the CC
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Figure  1  Bronchoscopic  images.  Panel  A:  Invagination  of  tracheal  posterior  wall  membrane  during  spontaneous  breathing  in  the
studied patient  with  narrowing  of  tracheal  lumen.  Panel  B:  Positioning  of  endoluminal  y  silicon  stent  (Dumon  type)  in  trachea  of
the studied  patient.  Panels  C  and  D:  Fully  covered  metal  stent  (Leufen)  placed  in  trachea  of  the  studied  patient.
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Tigure  2  Chest  CT  scans  of  the  studied  patient  show  invagina
f the  main  bronchi  (Panels  C,  D)  with  narrowing  of  airways  lum
ulse  generator  which  rapidly  inﬂates  and  deﬂates  the  vest
roducing  oscillations  to  the  chest  wall.Please  cite  this  article  in  press  as:  Bertella  E,  et  al.  Non-invasiv
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The  air  pulse  generator  was  set  at  pressure  level  2  and
requency  14.
HCFWO  alone  caused  worsening  of  dyspnea  probably
ecause  it  decreases  End  Expiratory  Lung  Volume  below  the
r
o
af  the  posterior  wall  membrane  of  trachea  (T)  (Panels  A,  B)  and
RB  is  for  right  main  bronchus,  LB  for  left  main  bronchus.
esidual  Functional  Capacity6 increasing  airway  resistance.
hus,  as  suggested  by  Perry  et  al.7,  we  added  a positive  expi-e  method  for  airway  clearance  in  a  patient  with  excessive
.  http://dx.doi.org/10.1016/j.rppnen.2016.08.004
atory  pressure  using  tPEP  set  at  8  cmH2O  to  maintain  airway
pened  during  the  oscillations.
While  Perry7 used  a  pressure-cycled  ventilator  to  add
 PEEP,  we  used  a  tPEP  with  a mouthpiece  to  make  the
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treatment  easier  and  more  feasible  at  home  for  the  patient
and  to  facilitate  secretions  expulsion  (which  can  be  difﬁ-
cult  when  wearing  a  facial  mask).  This  made  the  HFCWO
very  effective  and  JAT  continued  the  treatment  3  times  per
day  15  min/sessions,  achieving  stable  airway  cleaning  and
improvement  of  dyspnea.
During  the  airway  clearance  program  SpO2 was  moni-
tored:  it  did  not  change  from  the  basal  values  (i.e.  96--98%).
At  discharge  The  Borg  scale  of  dyspnea  improved  from
8  to  4  and  she  declared:  ‘‘I  feel  my  lungs  free  of
secretion,  during  the  treatment  I  feel  secretions  moving
upward’’  The  Quality  of  Life  score  (EQ-5D)  improved  from
50  to  85.
No  modiﬁcations  were  observed  in  lung  function.  HFCWO
and  tPEP  were  prescribed  at  home  3  times  per  day  every
day.  She  kept  to  the  treatment  and  after  48-month  follow-up
was  still  improved.  JAT  had  no  side  effect  from  treatment,
no  more  admissions  for  respiratory  symptoms  and  no  need
for  bronchoscopy.
Even  if  this  tool  is  not  a  treatment  for  the  disease,  it
ensured  the  patient  kept  her  lungs  clear  from  secretions  and
improved  her  dyspnea  and  quality  of  life.
We  did  not  study  the  effects  of  HFCWO  on  respiratory  sys-
tem  mechanics  of  this  patient  and,  as  EDAC  is  a  rare  disease,
we  could  not  conduct  a  randomized  trial.  Other  studies  and
more  patients  are  needed  to  verify  the  effectiveness  of  this
intervention  in  EDAC.
However,  we  think  that  the  association  of  HFCWO  and
tPEP  should  be  taken  into  consideration  when  any  other
treatment  fails  with  an  EDAC  patient.  This  is,  in  fact,  a  non-
invasive  and  safe  intervention  that  can  be  used  at  home  in
a  self-care  regime.
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